Related Experiment Videos
[Pregnancy in primary antiphospholipid syndrome. Proposal for a common management protocol]
1Service de Médecine Interne, CHU, Hôtel-Dieu, Nantes.
Summary
Antiphospholipid syndrome (APS) in pregnancy results in high rates of pregnancy loss. Aspirin alone showed some benefit, but further research is needed to confirm heparin
Area of Science:
- Reproductive immunology
- Obstetrics and Gynecology
- Thrombosis research
Context:
- Primary antiphospholipid syndrome (APS) presents significant obstetric challenges.
- Pregnancy outcomes in APS patients require specialized management strategies.
- Defining optimal care for pregnant women with APS is crucial.
Purpose:
- To retrospectively analyze pregnancy outcomes in women with primary APS.
- To identify effective management approaches for high-risk pregnancies in APS patients.
- To evaluate the efficacy of different therapeutic interventions.
Summary:
- This retrospective study analyzed 51 pregnancies in 15 women with primary APS.
- Untreated pregnancies resulted in a 76% embryonic or fetal loss rate.
- Preventive treatment yielded a higher live birth rate, with aspirin alone showing promise.
Impact:
- The obstetric prognosis for untreated APS is extremely poor.
- Further research is warranted to establish the benefits of heparin combined with aspirin.
- This study highlights the need for standardized treatment protocols for APS pregnancies.